vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $120.9M, roughly 1.5× Sprout Social, Inc.). On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 12.9%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $9.9M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 11.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.
FOLD vs SPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $120.9M |
| Net Profit | $1.7M | — |
| Gross Margin | 85.7% | 77.6% |
| Operating Margin | 8.6% | -9.0% |
| Net Margin | 0.9% | — |
| Revenue YoY | 23.7% | 12.9% |
| Net Profit YoY | -88.5% | — |
| EPS (diluted) | $0.00 | $-0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $120.9M | ||
| Q3 25 | $169.1M | $115.6M | ||
| Q2 25 | $154.7M | $111.8M | ||
| Q1 25 | $125.2M | $109.3M | ||
| Q4 24 | $149.7M | $107.1M | ||
| Q3 24 | $141.5M | $102.6M | ||
| Q2 24 | $126.7M | $99.4M | ||
| Q1 24 | $110.4M | $96.8M |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $17.3M | $-9.4M | ||
| Q2 25 | $-24.4M | $-12.0M | ||
| Q1 25 | $-21.7M | $-11.2M | ||
| Q4 24 | $14.7M | — | ||
| Q3 24 | $-6.7M | $-17.1M | ||
| Q2 24 | $-15.7M | $-16.9M | ||
| Q1 24 | $-48.4M | $-13.6M |
| Q4 25 | 85.7% | 77.6% | ||
| Q3 25 | 88.5% | 77.7% | ||
| Q2 25 | 90.2% | 77.7% | ||
| Q1 25 | 90.7% | 77.3% | ||
| Q4 24 | 90.1% | 78.1% | ||
| Q3 24 | 90.6% | 77.4% | ||
| Q2 24 | 91.1% | 77.5% | ||
| Q1 24 | 87.7% | 76.8% |
| Q4 25 | 8.6% | -9.0% | ||
| Q3 25 | 20.3% | -7.9% | ||
| Q2 25 | -6.1% | -11.0% | ||
| Q1 25 | -6.3% | -10.2% | ||
| Q4 24 | 10.7% | -12.8% | ||
| Q3 24 | 15.3% | -16.4% | ||
| Q2 24 | 11.8% | -16.6% | ||
| Q1 24 | -25.1% | -13.7% |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 10.2% | -8.1% | ||
| Q2 25 | -15.8% | -10.7% | ||
| Q1 25 | -17.3% | -10.3% | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | -4.8% | -16.6% | ||
| Q2 24 | -12.4% | -17.0% | ||
| Q1 24 | -43.9% | -14.0% |
| Q4 25 | $0.00 | $-0.18 | ||
| Q3 25 | $0.06 | $-0.16 | ||
| Q2 25 | $-0.08 | $-0.21 | ||
| Q1 25 | $-0.07 | $-0.19 | ||
| Q4 24 | $0.05 | $-0.25 | ||
| Q3 24 | $-0.02 | $-0.30 | ||
| Q2 24 | $-0.05 | $-0.30 | ||
| Q1 24 | $-0.16 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $95.3M |
| Total DebtLower is stronger | $392.7M | $40.0M |
| Stockholders' EquityBook value | $274.2M | $203.4M |
| Total Assets | $949.9M | $523.1M |
| Debt / EquityLower = less leverage | 1.43× | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $95.3M | ||
| Q3 25 | $263.8M | $90.6M | ||
| Q2 25 | $231.0M | $101.5M | ||
| Q1 25 | $250.6M | $100.9M | ||
| Q4 24 | $249.9M | $86.4M | ||
| Q3 24 | $249.8M | $82.9M | ||
| Q2 24 | $260.1M | $80.9M | ||
| Q1 24 | $239.6M | $69.2M |
| Q4 25 | $392.7M | $40.0M | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | $25.0M | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $203.4M | ||
| Q3 25 | $230.4M | $194.1M | ||
| Q2 25 | $204.3M | $184.6M | ||
| Q1 25 | $193.6M | $175.3M | ||
| Q4 24 | $194.0M | $166.6M | ||
| Q3 24 | $178.8M | $158.1M | ||
| Q2 24 | $132.5M | $152.1M | ||
| Q1 24 | $130.7M | $147.3M |
| Q4 25 | $949.9M | $523.1M | ||
| Q3 25 | $868.8M | $481.4M | ||
| Q2 25 | $815.3M | $422.9M | ||
| Q1 25 | $789.8M | $424.7M | ||
| Q4 24 | $785.0M | $428.3M | ||
| Q3 24 | $786.6M | $388.8M | ||
| Q2 24 | $749.5M | $393.6M | ||
| Q1 24 | $721.8M | $389.9M |
| Q4 25 | 1.43× | 0.20× | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | 0.15× | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $10.9M |
| Free Cash FlowOCF − Capex | $16.0M | $9.9M |
| FCF MarginFCF / Revenue | 8.6% | 8.2% |
| Capex IntensityCapex / Revenue | 0.2% | 0.9% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $39.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $10.9M | ||
| Q3 25 | $35.7M | $9.3M | ||
| Q2 25 | $-26.5M | $5.1M | ||
| Q1 25 | $7.8M | $18.1M | ||
| Q4 24 | $-3.9M | $4.1M | ||
| Q3 24 | $-23.0M | $9.0M | ||
| Q2 24 | $22.7M | $2.1M | ||
| Q1 24 | $-29.7M | $11.2M |
| Q4 25 | $16.0M | $9.9M | ||
| Q3 25 | $35.3M | $8.5M | ||
| Q2 25 | $-28.9M | $4.2M | ||
| Q1 25 | $7.5M | $16.7M | ||
| Q4 24 | $-4.2M | $3.3M | ||
| Q3 24 | $-23.3M | $8.5M | ||
| Q2 24 | $21.6M | $1.6M | ||
| Q1 24 | $-31.5M | $10.1M |
| Q4 25 | 8.6% | 8.2% | ||
| Q3 25 | 20.9% | 7.4% | ||
| Q2 25 | -18.7% | 3.7% | ||
| Q1 25 | 6.0% | 15.3% | ||
| Q4 24 | -2.8% | 3.0% | ||
| Q3 24 | -16.5% | 8.3% | ||
| Q2 24 | 17.0% | 1.6% | ||
| Q1 24 | -28.5% | 10.4% |
| Q4 25 | 0.2% | 0.9% | ||
| Q3 25 | 0.2% | 0.7% | ||
| Q2 25 | 1.6% | 0.8% | ||
| Q1 25 | 0.2% | 1.2% | ||
| Q4 24 | 0.2% | 0.8% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.9% | 0.5% | ||
| Q1 24 | 1.6% | 1.1% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
SPT
Segment breakdown not available.
